Robins Chad M's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Mar 3, 2026
- Accession no.
- 0001780649-26-000003
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 3, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $8.32M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robins Chad MCIK 0001780649 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | SSaleDisposed | −182,891 | $15.99 | −$2,924,427.09 | 2,276,354 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −289,024 | $15.82 | −$4,572,359.68 | 1,987,330 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −50,703 | $15.49 | −$785,389.47 | 1,936,627 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −2,380 | $16.15 | −$38,437 | 1,934,247 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.